60%

Share of hospitals that report receiving off-contract device requests from surgeons at least monthly. Source: Healthcare Supply Chain Association.

A surgeon requests a device that is not on the facility's approved product list. It happens in every hospital, and most ambulatory surgery centers regularly. The request is rarely frivolous. The surgeon has a clinical reason, a patient population that the existing portfolio does not fully serve, or recent exposure to a technology that they believe would improve outcomes. The administrator's challenge is evaluating that request fairly without creating a process so cumbersome that surgeons stop bringing legitimate clinical needs forward.

Building a structured off-contract device approval process serves both sides of that tension. It gives surgeons a clear and credible path to introduce new products. It gives administrators the clinical, compliance, and financial documentation they need to make an informed decision. And it gives the facility a record that demonstrates due diligence if a purchasing decision is ever reviewed.

What a structured approval process covers

An effective off-contract device approval process covers four areas. Clinical evidence: what published data support the device's safety and efficacy in the indicated application, and how does it compare to the existing standard of care? Regulatory status: Is the device FDA cleared or approved for the proposed use, and are there any open safety alerts or recalls? Cost and reimbursement: what is the cost per case, how does it compare to the existing approved alternative, and what is the reimbursement pathway? Vendor credentials: Is the distributor properly credentialed, insured, and compliant with the facility's vendor access standards?

A request that clears all four of these areas is a strong candidate for approval. One that fails on any of them requires either additional documentation from the requesting surgeon or a decline with a clear explanation. The process becomes faster over time as surgeons learn what documentation is expected and arrive at approval conversations with the right materials already prepared.

How the distributor relationship affects the approval process

A distributor who actively supports the approval process reduces the administrative burden on the facility significantly. A Synchrocare medical sales consultant can provide FDA clearance documentation, published clinical evidence, compliance credentials, and cost-per-case analysis as part of the product introduction conversation rather than requiring the facility to gather that information independently.

For procurement teams and surgical services directors managing a high volume of device requests, a distributor who comes to the approval conversation prepared with the documentation the facility needs is a meaningful operational advantage. It shortens the approval timeline, reduces back-and-forth, and demonstrates the kind of institutional seriousness that builds long-term distributor credibility.

Keeping the process visible to the surgical staff

The approval process only improves surgeon and facility relationships if surgeons understand it and trust that requests will be evaluated fairly. Publishing the approval criteria, setting a defined review timeline, and communicating decisions with a clear rationale builds the kind of procedural transparency that encourages surgeons to use the formal process rather than working around it.

Facilities that treat the off-contract approval process as a friction point rather than a structured pathway find that surgeon requests either stop coming through formal channels or accumulate without resolution. Neither outcome serves the facility, the surgeon, or the patient.

To learn more about how Synchrocare supports the device approval process for hospitals and ASCs, visit www.synchrocare.com.